Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study
**Background:** Recent evidence suggests that integrase strand transfer inhibitors are associated with greater weight gain than protease inhibitors in patients with human immunodeficiency virus (HIV-1). **Objectives:** To describe demographic and clinical characteristics of insured patients with HI...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2021-06-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://jheor.scholasticahq.com/article/24535-weight-change-and-predictors-of-weight-change-among-patients-initiated-on-darunavir-cobicistat-emtricitabine-tenofovir-alafenamide-or-bictegravir-emtr.pdf |